The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1

被引:34
作者
Congote, LF [1 ]
机构
[1] McGill Univ, Ctr Hlth, Endocrine Lab, Montreal, PQ H3A 1A1, Canada
关键词
alpha-antitrypsin; antithrombin III; proteinase inhibitor 9; LDL-receptor-related protein; CD91; CD36; U937; cells; interferon alpha 2;
D O I
10.1016/j.bbrc.2006.02.190
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serpin A1 (alpha 1-proteinase inhibitor) inhibits human immunodeficiency virus 1 (HIV-1) production by mechanisms which remain to be elucidated. The complex formation of serpin A1 with proteinases eliminates the proteolytic activity and generates a fragment corresponding to the serpin C-terminal 36-residue peptide. Here, we show that the C-terminal 26-residue peptide of serpin A1 (A1-C26) inhibits HIV-Iong terminal repeat (LTR)-driven transcription in epithelial cells transfected with HIV-1 LTR promoter-driven genes. A1-C26 increased STAT1 phosphorylation and strongly reduced viral expression in a monocytic cell line infected with HIV-1 NL4-3. This reduction of expression was also observed in HIV-1 infected, PHA-activated peripheral blood mononuclear cells. In HIV-1 infected cells, the inhibitory activity of HIV-1 caused by B9-C23 and C1-C26, the A1-C26 homologues corresponding to the C-terminal sections of serpin B9 and serpin C1, was much lower than that obtained with Al-C26. These serpin peptides represent a novel class of antiviral agents. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:617 / 622
页数:6
相关论文
共 31 条
[1]  
Bovolenta C, 1999, J IMMUNOL, V162, P323
[2]   Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system [J].
Chang, LJ ;
Urlacher, V ;
Iwakuma, T ;
Cui, Y ;
Zucali, J .
GENE THERAPY, 1999, 6 (05) :715-728
[3]   CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from α-defensin-1 HIV inhibition [J].
Chang, TLY ;
François, F ;
Mosoian, A ;
Klotman, ME .
JOURNAL OF VIROLOGY, 2003, 77 (12) :6777-6784
[4]   RETRACTED: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010) [J].
Chiu, YL ;
Soros, VB ;
Kreisberg, JF ;
Stopak, K ;
Yonemoto, W ;
Greene, WC .
NATURE, 2005, 435 (7038) :108-114
[5]   The C-terminal 26-residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: role of protein kinase C and CD47 [J].
Congote, LF ;
Temmel, N .
FEBS LETTERS, 2004, 576 (03) :343-347
[6]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[7]   The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1 [J].
Degryse, B ;
Neels, JG ;
Czekay, RP ;
Aertgeerts, K ;
Kamikubo, Y ;
Loskutoff, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22595-22604
[8]   Preparation of a recombinant chimaera of insulin-like growth factor II and interleukin 3 with high proliferative potency for haemopoietic cells [J].
DiFalco, MR ;
Congote, LF .
BIOCHEMICAL JOURNAL, 1997, 326 :407-413
[9]   A QUANTITATIVE BIOASSAY FOR HIV-1 BASED ON TRANS-ACTIVATION [J].
FELBER, BK ;
PAVLAKIS, GN .
SCIENCE, 1988, 239 (4836) :184-187
[10]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193